FindTrial
Sign In

antiangiogenesis therapy

PROCEDURE10 trials

Sponsors

National Cancer Institute (NCI), Barbara Ann Karmanos Cancer Institute, SWOG Cancer Research Network, The Cleveland Clinic, Eastern Cooperative Oncology Group

Conditions

Adenocarcinoma of the PancreasChemo-free TherapyColorectal CancerGastrointestinal Carcinoid TumorHigh-grade Squamous Intraepithelial LesionIslet Cell CarcinomaKidney CancerMetastatic Cancer

Phase 1

Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors
WithdrawnNCT00052403
Barbara Ann Karmanos Cancer InstituteUnspecified Adult Solid Tumor, Protocol Specific
Start: 2002-02-28Updated: 2014-01-16

Phase 2

Celecoxib in Preventing Skin Cancer
WithdrawnNCT00025051
National Cancer Institute (NCI)Non-melanomatous Skin Cancer
Updated: 2013-03-22
S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix
WithdrawnNCT00072540
SWOG Cancer Research NetworkHigh-grade Squamous Intraepithelial Lesion, Stage 0 Cervical Cancer
Updated: 2013-11-08
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma
WithdrawnNCT00112879
The Cleveland ClinicRefractory Plasma Cell Neoplasm, Stage III Multiple Myeloma, Stage II Multiple Myeloma +1
Updated: 2013-07-10
Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors
WithdrawnNCT00227773
Eastern Cooperative Oncology GroupGastrointestinal Carcinoid Tumor, Islet Cell Carcinoma
Updated: 2015-10-08
Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer
WithdrawnNCT00244920
OHSU Knight Cancer InstituteProstate Cancer
Start: 2002-01-31End: 2007-06-30Updated: 2012-05-28
Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer
WithdrawnNCT00253526
National Cancer Institute (NCI)Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer +2
Updated: 2015-04-28
Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy
TerminatedNCT00390364
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsColorectal Cancer
Start: 2006-10-31End: 2007-10-31Updated: 2014-10-08
Neoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLC
Not yet recruitingNCT07231575
Sun Yat-sen UniversityChemo-free Therapy, Neoadjuvant Immunotherapy, NSCLC
Start: 2025-11-10End: 2032-05-30Target: 39Updated: 2025-11-18

Unknown Phase

Ultrasound in Assessing Antiangiogenic Treatment in Patients With Advanced Kidney Cancer
NCT01105364
National Cancer Institute, FranceKidney Cancer, Metastatic Cancer
Start: 2007-12-31Target: 50Updated: 2013-08-12